The Enterprise Value as of June 2026 (TTM) for Amphastar Pharmaceuticals, Inc. (AMPH) is 1.40B

According to Amphastar Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.40B. This represents a change of -11.65% compared to the average of 1.59B of the last 4 quarters.

Amphastar Pharmaceuticals, Inc. (AMPH) Historical Enterprise Value (quarterly & annually)

How has AMPH Enterprise Value performed in the past?

The mean historical Enterprise Value of Amphastar Pharmaceuticals, Inc. over the last ten years is 1.43B. The current 1.40B Enterprise Value has changed 9.72% with respect to the historical average. Over the past ten years (40 quarters), AMPH's Enterprise Value was at its highest in in the December 2023 quarter at 3.45B. The Enterprise Value was at its lowest in in the March 2017 quarter at 627.65M.

Amphastar Pharmaceuticals, Inc. (AMPH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Amphastar Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Amphastar Pharmaceuticals, Inc. (AMPH) Average Enterprise Value

How has AMPH Enterprise Value performed in the past?

The current Enterprise Value of Amphastar Pharmaceuticals, Inc. (AMPH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Amphastar Pharmaceuticals, Inc. (AMPH) Enterprise Value vs. Peers

How is AMPH’s Enterprise Value compared to its peers?

Amphastar Pharmaceuticals, Inc.’s Enterprise Value is less than Dynavax Technologies Corporation (1.95B), less than Collegium Pharmaceutical, Inc. (1.66B), greater than Pacira BioSciences, Inc. (1.17B), greater than CureVac N.V. (523.37M), greater than Embecta Corp. (1.36B), less than Harrow Health, Inc. (1.61B), less than Syndax Pharmaceuticals, Inc. (1.83B), greater than Inhibrx Biosciences, Inc. (1.20B), less than AdaptHealth Corp. (3.34B), greater than Beta Bionics, Inc. (624.19M),

Build a custom stock screener for Amphastar Pharmaceuticals, Inc. (AMPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amphastar Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amphastar Pharmaceuticals, Inc. (AMPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amphastar Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.